Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home

This is the text extract for Schedule 3: Market information, browse documents here.


Schedule 3: Market information 1. DHB Hospital usages below are expressed as the unit volume in the year ending 30 June 2005. The values are approximate and indicative only. PHARMAC makes no representation as to the accuracy of these figures or as to the level of sales or likely sales of any product. In particular, if these figures change at any time during the request for proposals process, PHARMAC is not obliged to notify you of any such change. You acknowledge and agree that in submitting your proposal you will rely on your own knowledge, skill and independent advice or assessment of the market size and PHARMAC is to have no liability in that regard.

2.

DHB Hospital usage of various anaesthetics in the year ending 30 June 2005

Formulation Isoflurane Desflurane Sevoflurane Propofol +/- EDTA, Inj 10 mg per ml, 100 ml Propofol +/- EDTA, Inj 10 mg per ml, 20 ml Propofol +/- EDTA, Inj 10 mg per ml, 50 ml Propofol +/- EDTA, Inj 10 mg per ml, 50 ml, PFS Propofol +/- EDTA, Inj 20 mg per ml, 50 ml Propofol +/- EDTA, Inj 20 mg per ml, 50 ml, PFS Units 484,262 738,000 2,012,194 5,279 309,150 2,140 15,772 600 708 Unit Type ml ml ml vial vial vial syringe vial syringe

Metadata

Title

Schedule 3: Market information

Abstract

1. DHB Hospital usages below are expressed as the unit volume in the year ending 30 June 2005. The values are approximate and indicative only. PHARMAC makes no representation as to the accuracy of these figures…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.